Clinical Trial Update: Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing atomoxetine to placebo in children and adolescents with ADHD and oppositional defiant disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Oppositional Defiant Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder | Phase 3 | Status: COMPLETED